Thank you so much for sharing Rison, great to know what the end...

First 1126 Last

Share
Profile

Follow
Sabre1973

1,474 Posts.

140

09/08/18

18:47

Post #: 34841535
Share

Originally posted by rison ↑

Hi All,

Not sure if this thread is for information or just having a go at everyone but thought I would expand a bit more on my last post as I see that a few people may be missing even more of this product.

As I mentioned before I work in a small facility, we are probably one that they classify in "trial". My facility is committed to sign up to it though after the trial.
While we are currently running around 50% of our residents with dementia we are also using it on non dementia residents and we will be getting licenses for use in our whole facility not only on a percentage of residents. So the market really is not only dementia patients but anyone in an aged care facility.

My personal opinion after being in the aged care industry for a number of years now it is not a quick process to get new technology in to aged care. I think it proves that it works and the industry wants it as the smaller facilities are picking it up as it is much easier for them.

To get into the big Bupa/Baptistcare/Anglicare/Regis etc will take much longer just because of how much longer their decision making and processes take. It would not surprise me if for the next 4-6 months we see quite a few of the smaller or mid tier RAC's pick it up with the larger ones announcing end of this year/early next year.

Quite happy for the share price to stay around this level at the moment as I can continue to build my holdings! I am holding for the long term!

Enough information and talk back to bantering now...

Expand

Thank you so much for sharing Rison, great to know what the end users opinion is of our App and knowing it's making a difference, cheers

PCK Price at posting: 4.8¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

There are more pages in this discussion • 19,287 more messages in this thread...

First 1126 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 2.8¢		Change -0.002(6.67%)		Mkt cap ! $47.43M

Open	High	Low	Value	Volume
3.0¢	3.0¢	2.8¢	$18.21K	622.2K

Buyers (Bids)

No.	Vol.	Price($)
4	1343466	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	6261	2

View Market Depth

No.	Vol.	Price($)
4	1343466	0.028
11	1652439	0.027
2	250000	0.026
3	3000000	0.025
2	165079	0.024

Price($)	Vol.	No.
0.029	6261	2
0.030	951999	1
0.032	24900	1
0.033	410208	3
0.034	5874	1

Last trade - 14.25pm 11/07/2024 (20 minute delay)

PCK (ASX) Chart

Thank you so much for sharing Rison, great to know what the end...

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thank you so much for sharing Rison, great to know what the end...

Top Stories

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News